よむ、つかう、まなぶ。
Global Health Vision of Ministry of Health, Labour and Welfare of Japan (12 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_42939.html |
| 出典情報 | 「厚生労働省国際保健ビジョン」の公表について（8／26）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
WHO and the World Bank will jointly offer support for capacity building with
policymakers and practitioners in health and finance ministries in LIMCs by providing
training and expert consultation on health financing. In addition, while utilizing existing
global information and analysis on UHC, the Hub will advise on policy options related
to UHC and generate new data and evidence necessary to address the financing gap.
To promote UHC and to strengthen health system resilience, it will focus on basic
health finance as well as financing other emerging and critical health issues.
The Government of Japan will support the activities of WHO and the World Bank
by providing necessary human resources and financial contributions, while offering
insights based on Japan's experience with UHC-related areas, such as health care
and long-term care systems. WHO and the World Bank will collaborate by leveraging
their respective strengths in data, information, and capacity building, and will further
develop training programs and curricula.
In addition, the Government of Japan, in collaboration with WHO and the World
Bank, will involve multiple stakeholders, including other international financial
institutions, international health-related organizations, bilateral aid agencies, the
private sector, and relevant regional offices and organizations - such as WHO regional
offices - to promote broad engagement, dialogue, and capacity building on UHC.
③ Timeline
The UHC Knowledge Hub, staffed by experts from WHO and World Bank, will be
established in Tokyo area. In preparation for the establishment of the WHO Office in
FY2026, a preparatory organization will be set up in FY2025. The Hub will consist of
a "WHO Office in Tokyo Area (tentative name),” “WB Tokyo UHC Team (tentative
name)," and a coordinating body that will manage its operations.
(2) International Strategy for Strengthening Drug Discovery Infrastructure
① Purpose
As new modalities such as next-generation biopharmaceuticals become
mainstream of drug discovery, the need to collaborate with global public-private
partnerships, rather than domestic ones, is increasing for the "ecosystem" involved in
drug discovery. Japan has pioneering research in academia, including universities,
startup companies, advanced medical institutions capable of conducting clinical trials,
and pharmaceutical manufacturers with a large pool of human resources and capital.
12
policymakers and practitioners in health and finance ministries in LIMCs by providing
training and expert consultation on health financing. In addition, while utilizing existing
global information and analysis on UHC, the Hub will advise on policy options related
to UHC and generate new data and evidence necessary to address the financing gap.
To promote UHC and to strengthen health system resilience, it will focus on basic
health finance as well as financing other emerging and critical health issues.
The Government of Japan will support the activities of WHO and the World Bank
by providing necessary human resources and financial contributions, while offering
insights based on Japan's experience with UHC-related areas, such as health care
and long-term care systems. WHO and the World Bank will collaborate by leveraging
their respective strengths in data, information, and capacity building, and will further
develop training programs and curricula.
In addition, the Government of Japan, in collaboration with WHO and the World
Bank, will involve multiple stakeholders, including other international financial
institutions, international health-related organizations, bilateral aid agencies, the
private sector, and relevant regional offices and organizations - such as WHO regional
offices - to promote broad engagement, dialogue, and capacity building on UHC.
③ Timeline
The UHC Knowledge Hub, staffed by experts from WHO and World Bank, will be
established in Tokyo area. In preparation for the establishment of the WHO Office in
FY2026, a preparatory organization will be set up in FY2025. The Hub will consist of
a "WHO Office in Tokyo Area (tentative name),” “WB Tokyo UHC Team (tentative
name)," and a coordinating body that will manage its operations.
(2) International Strategy for Strengthening Drug Discovery Infrastructure
① Purpose
As new modalities such as next-generation biopharmaceuticals become
mainstream of drug discovery, the need to collaborate with global public-private
partnerships, rather than domestic ones, is increasing for the "ecosystem" involved in
drug discovery. Japan has pioneering research in academia, including universities,
startup companies, advanced medical institutions capable of conducting clinical trials,
and pharmaceutical manufacturers with a large pool of human resources and capital.
12